← Leaderboards
Laila M Poisson
Henry Ford Health System
$2,755,953
Attributed
$2,755,953
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $619.8K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,755,953 · 1
By mechanism
R01$2,755,953 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Dna Sequence”
- Leonard Freedman · Leidos Biomedical Research, Inc.$71,124,067
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$31,640,785
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,188,684
- Badri N Vardarajan · University Of Miami School Of Medicine$23,982,327
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
Research focus
Dna SequenceDocumentationAstrocytesDna MethylationBrainAffectCaringCellsCell TypeAccountingChromosome DeletionClinical Decision SupportBrain NeoplasmsClinical PracticeCopy Number PolymorphismDatabasesData ResourceDesignDiagnosisDiagnosticAdjuvantDideoxy Chain Termination Dna SequencingDisease ProgressionEpigenomics
Grant awards (6)
Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care$232,019
R01 · FY2023 · CA · contact PI
Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care$388,738
R01 · FY2022 · CA · contact PI
Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care$346,510
R01 · FY2021 · CA · contact PI
Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care$619,783
R01 · FY2020 · CA · contact PI
Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care$591,350
R01 · FY2019 · CA · contact PI
Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care$577,553
R01 · FY2018 · CA · contact PI